Phase 2 Open-Label study of MEDI-551 and Bendamustine vs Rituximab and Bendamustine in Adults With Relapsed or Refractory CLL
(2014) 50th Annual Meeting of the American Society if Clinical Oncology — Location: Chicago (30.May.2014)
Files
No attached file found for this publication.
Details
- Authors
- Affiliations
Citations
Gladstone, D., André, M., Zaucha, J., Assouline, S., Bellam, N., Cascavilla, N., Jourdan, E., Panwalkar, A., Patti, C., Schulte, C., Zaja, F., Goswami, T., Elgeioushi, N., Streicher, K., Bao, H., & Spaner, D. (2014). Phase 2 Open-Label study of MEDI-551 and Bendamustine vs Rituximab and Bendamustine in Adults With Relapsed or Refractory CLL. 50th Annual Meeting of the American Society if Clinical Oncology, Chicago. https://hdl.handle.net/2078.5/51089